VISWANADHAN KRISHNAN (Chief Corp Dev & Strategy) sold 36.5% of their position (2.96K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $82.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2026ACC: 0001439222-26-000049
Officer· Chief Corp Dev & Strategy
Since Mar 2026
-2.96K
Net shares
Net seller
$82.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.10K acquired · 11.06K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+8.10K
Price / share
—
Trade value
—
% of position
New position
3/5/2026
0.00→8.10K
Common stock
Direct
Shares
−2.96K
Price / share
$27.80
Trade value
$82.26K
% of position
36.5%
3/5/2026
8.10K→5.14K
Total
Net shares
+5.14K
Net value
-$82.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 3/5/2026 | M · Option Exercise | +8.10K | — | — | New position | 0.00 | 8.10K |
| Common stock Direct | 3/5/2026 | S · Sale | −2.96K | $27.80 | $82.26K | 36.5% | 8.10K | 5.14K |
| Total | +5.14K | -$82.26K | ||||||
Derivative Transactions1
Restricted stock units
Direct
Converts to
Common stock
8.10K shares
Shares
−8.10K
Strike price
Held after
16.20K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted stock units Direct | Common stock8.10K shares | 3/5/2026 | M · Option Exercise | −8.10K | — | 16.20K |